logo

PAVM

PAVmed·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

PAVM fundamentals

PAVmed (PAVM) released its earnings on Nov 12, 2025: revenue was 5.00K (YoY -99.50%), missed estimates; EPS was -0.29 (YoY +46.30%), missed estimates.
Revenue / YoY
5.00K
-99.50%
EPS / YoY
-0.29
+46.30%
Report date
Nov 12, 2025
PAVM Earnings Call Summary for Q3,2025
  • Lucid Milestone: Medicare coverage endorsement for EsoGuard, $27M capital raise extends runway to 2026.
  • Veris Growth: Implantable device on track for 2026 FDA submission, expanding commercial reach with clinical support services.
  • New Technology: Breakthrough endoscopic imaging partnership with Duke/UNC nearing definitive agreement.
  • Financial Stability: Restructured debt, cash flow breakeven with $446K non-GAAP loss Q3.
EPS
Revenue

Revenue & Expenses

PAVM has released its 2025 Q3 earnings report, with revenue of 5.00K, reflecting a YoY change of -99.50%, and net profit of -6.01M, showing a YoY change of -109.90%. The Sankey diagram below clearly presents PAVM's revenue sources and cost distribution.

Key Indicators

PAVmed (PAVM) key financial stats and ratios, covering profitability, financial health, and leverage.
PAVmed (PAVM)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
PAVmed (PAVM)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
PAVmed (PAVM)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does PAVmed (PAVM) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track PAVmed (PAVM) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield